For Investors - Segra International
Segra International is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.
Segra, Cannabis Micropropagation, Cannabis Tissue Culture, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility, Micropropagation
page-template,page-template-full_width,page-template-full_width-php,page,page-id-125,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

For Investors

Segra provides plant micropropagation service programs for commercial growers and nurseries.  We bring together a world-class team including experts from the fields of plant tissue culture, molecular biology, agronomy, and nursery operations, to produce high quality, clean-stock plants for the agricultural and horticultural sectors. 

Segra is an advanced stage applicant with Health Canada to become a Licensed Producer and legal distributor of medical Cannabis spp.. We are currently developing a cannabis micropagation production facility in the state of California to provide starting plant materials to the largest cannabis market in the world.

The company’s emphasis on quality, integrity, and science continues to attract and retain a team of world-class multidisciplinary science and business professionals.

For investor relations or
more information please contact:

Sam Woolf
Investor Relations
(604) 674-1060